Specificity and Function of the Individual Amino Acids of an Important Determinant of Human Immunodeficiency Virus Type 1 that Induces Neutralizing Activity
An important antigenic determinant of human immunodeficiency virus type 1 that induces neutralizing activity in infected humans and chimpanzees was previously mapped with nonapeptides between amino acids 307 and 320 on the external envelope glycoprotein (gp120) of strain HTLV-IIIB (molecular clone BH 10) and amino acids 320 to 330 of strain HTLV-IIIRF. Using different sera we found different reactive nonapeptides that overlapped and shared a tetrapeptide, GPGR. This tetrapeptide, which is the same in HTLV-IIIB and HTLV-IIIRF, is flanked by amino acids that vary between virus strains. Because GPGR is predicted to form a β-turn and is flanked by two cysteine residues that may form a disulphide bridge, a hairpin-like structure is suggested for this part of gp120. The tetrapeptide GPGR and the reactive peptides are located on top of this structure, well exposed to antibodies. We determined the role of the individual amino acids in antibody binding using three sets of peptide analogues derived from three reactive nonapeptides (two of strain HTLV-IIIB which overlapped and one of strain HTLV-IIIRF). Each set contained peptide analogues in which each amino acid was replaced, one at a time, by all genetically encoded amino acids. At least five consecutive amino acids in each nonapeptide were essential for antibody binding. They include amino acids of GPGR and potentially provide the virus with ample opportunity to escape immune surveillance.
BahraouiE.,
Clerget-RaslainB.,
ChapuisF.,
OliverR.,
ParraviciniC.,
YagelloM.,
MontagnierL.,
GluckmanJ. C.1988; A molecular mechanism of inhibition of HIV-1 binding to CD4+ cells by monoclonal antibodies to gp110.. AIDS 2:165–169
De WolfF.,
GoudsmitJ.,
PaulD. A.,
LangeJ. M. A.,
HooijkaasC.,
SchellekensP.,
CoutinhoR. A.,
Van Der NoordaaJ.1987; Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.. British Medical Journal 295:513–516
GajdusekD. C.,
GibbsC. J.JR, , Rodgers-JohnsonP.,
AmyxH. L.,
AsherD. M.,
EpsteinL. G.,
SarinP. S.,
GalloR. C.,
MaluishA.,
ArthurL. O.,
MontagnierL.,
MildvanD.1985a; Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients.. Lancet i:55–56
GajdusekD. C.,
GibbsC. J.JR,
EpsteinL. G.,
AmyxH. L.,
Rodgers-JohnsonP.,
ArthurL. O.,
GalloR. C.,
SarinP.,
MontagnierL.,
MildvanD.,
Mathur-WaghU. O.,
GoudsmitJ.1985b; Transmission of human T-lymphotropic retrovirus infection to chimpanzees using brain and other tissues from AIDS patients.. In Proceedings of the International Congress for Infectious Diseases, Cairo.168–172 Rome: Edizioni Luigi Possi;
GeysenH. M.,
MeloenR. H.,
BartelingS. J.1984; Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.. Proceedings of the National Academy of Sciences, U.S.A. 81:3998–4002
GeysenH. M.,
BartelingS. J.,
MeloenR. H.1985; Small peptides induce antibodies with a sequence and structural requirements for binding antigen comparable to antibodies raised against the native protein.. Proceedings of the National Academy of Sciences, U.S.A. 82:178–182
GeysenH. M.,
RoddaS. J.,
MasonM. J.1986; The delineation of peptides able to mimic assembled epitopes.. In Synthetic peptides as antigens. Ciba Foundation Symposia119130–149PorterR.,
WhelanJ.
London: Pitman;
GoudsmitJ.,
De WolfF.,
PaulD. A.,
EpsteinL. G.,
LangeJ. M. A.1986; Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebro-spinal fluid during acute and chronic infection.. Lancet ii:177–180
GoudsmitJ.,
EpsteinL.,
PaulD. A.,
Van Der HelmH. J.,
AscherD. M.,
YanagiharaR.,
WolffA. V.,
GibbsC. J.JR.,
GajdusekD. C.1987; Intra-blood-brain-barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees.. Proceedings of the National Academy of Sciences, U.S.A. 84:3876–3880
GoudsmitJ.,
DebouckC.,
MeloenR. H.,
SmitL.,
BarkkerM.,
AsherD. M.,
WolffA. V.,
GibbsC. I.JR.,
GajdusekD. C.1988a; HIV-1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.. Proceedings of the National Academy of Sciences, U.S.A. 85:4478–4482
GoudsmitJ.,
ThiriartC.,
SmitL.,
BruckC.,
GibbsC. J.JR.1988c; Temporal development of cross-neutralization between HTLV-VIIB and HTLV-IIIRF in experimentally infected chimpanzees.. Vaccine 6:229–232
GoudsmitJ.,
SmitL.,
MeloenR. H.1988d; Conserved location and structure of a HIV-1 neutralization epitope with restricted antibody binding specificity.. Proceedings UCLA Symposium: Technological Advances in Vaccine Development 84:345–355
GoudsmitJ.,
MeloenR. H.,
RuscheJ. R.,
PutneyS. D.1988e; Baculovirus-expressed gp160 of HIV-1 induces antibodies with isolate-specific binding to a nine-amino acid sequence related to type-specific cell fusion inhibition.. AIDS 2:231
HoD. D.,
SangadharanM. G.,
HirschM. S.,
SchooleyR. T.,
RotaT. R.,
KennedyR. C.,
ChanhT. C.,
SatoV. L.1987; Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins.. Journal of Virology 61:2024–2028
HoD. D.,
KaplanJ. C.,
RackauskasI. E.,
GurneyM. E.1988; Second conserved domain of gp120 is important for HIV infectivity and antibody formation.. Science 239:1021–1023
IshiiS.,
IshitaniR.1975; Equine infectious anemia. In Advances in Veterinary Science and Comparative Medicine19195–219BrandlyC. A.,
CorneliusC. E.
London: Academic Press;
ModrowS.,
HahnB. H.,
ShawG. M.,
GalloR. C.,
Wong-StaalF.,
De WolfH.1987; Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.. Journal of Virology 61:570–578
MyersG.,
RabsonA. B.,
JosephsS. F.,
SmithT. F.,
Wong-StaalF.1987; . Human Retroviruses and AIDS. Los Alamos: Theoretical Biology and Biophysics Group T-10.;
NarayanO.,
ClementsJ. E.,
GriffinD. E.,
WolinskyJ. S.1981; Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus.. Infection and Immunity 32:1045–1050
NimmoR. G.,
LewA. M.,
StanleyC. M.,
StewardM. W.1984; Influence of antibody affinity on the performance of different antibody assays.. Journal of Immunological Methods 72:177–187
PalkerT. J.,
ClarkM. E.,
LangloisA. J.,
MatthewsT. J.,
WeingoldK. J.,
ArandallR. R.,
BolognesiD. P.,
HaynesB. F.1988; Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.. Proceedings of the National Academy of Sciences, U.S.A. 85:1932–1936
PutneyS. D.,
MatthewsT. J.,
RobeyW. G., LynnD. L.,
Robert-GuroffM.,
MuellerW. T.,
LangloisA. J.,
GhrayebJ.,
PettewayS. R.,
WeinholdK. J.,
FischingerP. J.,
Wong-StaalF.,
GalloR. C.,
BolognesiD. P.1986; HTLV-IIIB/LAV neutralizing antibodies to an E. coli-produced fragment of the virus envelope.. Science 234:1392–1395
RuscheJ. R.,
LynnD. L.,
Robert-GuroffM.,
LangloisA. J.,
LyerlyH. K.,
CarsonH.,
KrohnK.,
RanluA.,
GalloR. C.,
BolognesiD. P.,
PutneyS. D.,
MatthewsT. J.1987; Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells.. Proceedings of the National Academy of Sciences, U.S.A. 84:6924–6928
RuscheJ. R.,
JavaherianK.,
McdanalC.,
PetroI.,
LynnD. L.,
GrimailaR.,
LangloisA.,
GalloR. C.,
ArthurL. O.,
FischingerP. J.,
BolognesiD. P.,
PutneyS. D.,
MatthewsT. J.1988; Antibodies that inhibit fusion of HIV infected cells bind a 24 amino acid sequence of the viral envelope, gp 120.. Proceedings of the National Academy of Sciences, U.S.A. 85:3198–3202
Specificity and Function of the Individual Amino Acids of an Important Determinant of Human Immunodeficiency Virus Type 1 that Induces Neutralizing Activity